Search results for: Health Care Systems
Filter search results
The Dynamics of Drug Shortages
9 January 2024
…include higher out-of-pocket payments for patients as well as more resources being diverted to controlling shortages rather than other healthcare resource utilisation. Recommendations Governments around the world have been working…
Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead
1 January 2020
…adult perspective (considering their own health) and EQ-5D-Y health states from a child perspective (considering the health of a 10-year-old child). Overall, respondents gave lower values under the adult perspective…
Migraine
1 September 1991
…does not shorten life or cause permanent injury. In contrast to many current health problems examined in the Office of Health Economics’ series, the morbidity generated by migraine does not…
Health Expenditure in the UK
1 May 1986
Share this: Download publication Robert Chew In the UK in 1984 the combined expenditure on health care services by both the public and private sectors rose to a record total…
Overview of the Economics of the Market for Medicines in the UK
29 March 2012
…His presentation covers the key issues, from drug development through health technology assessment and market access. Economics of the Market for Medicines in the UK from Office of Health Economics…
The Tougher the Better: The Effect of GP Performance Thresholds in Scotland
20 April 2012
…that the QOF achievement has had a negligible impact on health outcomes. The OHE’s Yan Feng and her colleagues take a closer look at the effect of changes in the…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 May 2012
…affect their health in future. Current pricing and reimbursement systems for diagnostics, however, are not efficient and provide poor incentives for new diagnostic approaches. Prices often are driven by administrative…
OHE Models Future UK Medicines Spending for the ABPI
3 July 2012
The Office of Health Economics has developed and run a model for the ABPI to project UK NHS expenditure on medicines. On 2 July, the ABPI released its projections for…
OHE Conference on the Future of Drug Development – Register Now
5 September 2012
…of UK and EU regulatory agencies, the pharmaceutical industry and payers — as well as leading experts in health technology assessment, pricing and reimbursement, and R&D structure and incentives. Among…